Загрузка...
Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia
BACKGROUND: Statins reduce plasma low-density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (hsCRP) levels. Rosuvastatin 10 mg daily appears to be more potent in reducing LDL-C than simvastatin 40 mg, but the relative effect of these two statin doses on hsCRP is unknown. ME...
Сохранить в:
| Опубликовано в: : | Lipids Health Dis |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4568069/ https://ncbi.nlm.nih.gov/pubmed/26365713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-015-0116-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|